Cure My Disease

Don't miss your cure!

 Log in / Sign up

App aims to boost breast milk donations to save preterm babies

NCT ID NCT07477041

Completed Knowledge-focused Sponsor: National University of San Marcos, Peru Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a mobile app called Amamantapp could increase knowledge and positive attitudes about breast milk donation among new mothers in Peru. 112 breastfeeding mothers were randomly assigned to use the app for 60 days or to a control group. Researchers measured changes in knowledge, attitudes, and donation practices using a questionnaire. The goal is to address a shortage of donor milk that contributes to deaths of preterm babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mobile app (Amamantapp) with educational modules on breast milk donation
What this could lead to
If it works, this app could increase the number of breast milk donors, helping to save preterm babies who urgently need donated milk.
What could go wrong
This is a small, completed trial in one hospital in Peru, so results may not apply elsewhere. The app only measures changes in knowledge and attitudes, not actual donation rates or baby health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST FEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST FEEDING HEALTH KNOWLEDGE ATTITUDES AND PRACTICE

Contacts and locations

Locations

  • National Maternal and Perinatal Hospital (NMPH)

    Lima, Lima Province, Peru

More trials for these conditions

Other studies related to the condition(s) this trial covers.